Abrogation of Ifnar1 in murine cancer cells resulted in an enhanced antitumor response after IR dependent on CD8+ T cells, which generally did not lead to increased numbers, augmented cytotoxic markers, or reduced exhaustion of tumor-infiltrating CD8+ T cells. The gene discussed is IFNAR1; the disease is cancer.